1 Setchell, KDR, Borriello, SP, Hulme, P, et al. (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 40, 569–578.
2 Franke, AA, Halm, BM, Kakazu, K, et al. (2009) Metabolism, bioavailability, and analysis of dietary isoflavones. In Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology [Fraga, C, editor]. : Wiley & Sons.
3 Setchell, KD & Clerici, C (2010) Equol: pharmacokinetics and biological actions. J Nutr 140, 1363S–1368S.
4 Yan, L & Spitznagel, EL (2009) Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89, 1155–1163.
5 Yan, L, Spitznagel, EL & Bosland, MC (2010) Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19, 148–158.
6 Park, SY, Wilkens, LR, Franke, AA, et al. (2009) Urinary phytoestrogen excretion and prostate cancer risk: a nested case–control study in the Multiethnic Cohort. Br J Cancer 101, 185–191.
7 Cassidy, A (2005) Dietary phyto-oestrogens: molecular mechanisms, bioavailability and importance to menopausal health. Nutr Res Rev 18, 183–201.
8 Ingram, D, Sanders, K, Kolybaba, M, et al. (1997) Case–control study of phyto-oestrogens and breast cancer. Lancet 350, 990–997.
9 Dai, Q, Franke, AA, Jin, F, et al. (2002) Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11, 815–821.
10 Goodman, MT, Shvetsov, YB, Wilkens, LR, et al. (2009) Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Prev Res (Phila Pa) 2, 887–894.
11 Trock, BJ, Hilakivi-Clarke, L & Clarke, R (2006) Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98, 459–471.
12 Zheng, W, Dai, Q, Custer, LJ, et al. (1999) Urinary excretion of isoflavones and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8, 35–40.
13 Chen, Z, Zheng, W, Custer, LJ, et al. (1999) Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoid in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 33, 82–89.
14 Thanos, J, Cotterchio, M, Boucher, BA, et al. (2006) Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17, 1253–1261.
15 Korde, LA, Wu, AH, Fears, T, et al. (2009) Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 18, 1050–1059.
16 Shu, XO, Jin, F, Dai, Q, et al. (2001) Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10, 483–488.
17 Wu, AH, Wan, P, Hankin, J, et al. (2002) Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491–1496.
18 Lee, SA, Shu, XO, Li, H, et al. (2009) Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am J Clin Nutr 89, 1920–1926.
19 Lampe, JW, Karr, SC, Hutchins, AM, et al. (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217, 335–339.
20 Rowland, IR, Wiseman, H, Sanders, TA, et al. (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36, 27–32.
21 Morton, MS, Wilcox, G, Wahlqvist, ML, et al. (1994) Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 142, 251–259.
22 Setchell, KD & Cole, SJ (2006) Method of defining equol-producer status and its frequency among vegetarians. J Nutr 136, 2188–2193.
23 Akaza, H, Miyanaga, N, Takashima, N, et al. (2004) Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34, 86–89.
24 Franke, AA, Halm, BM & Ashburn, LA (2008) Urinary isoflavones are increased in adults, but decreased in children, consuming soy when on oral antibiotic therapy. Nutr Cancer 60, 627–635.
25 Lampe, JW (2009) Is equol the key to the efficacy of soy foods? Am J Clin Nutr 89, 1664S–1667S.
26 Atkinson, C, Frankenfeld, CL & Lampe, JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230, 155–170.
27 Frankenfeld, CL, Atkinson, C, Thomas, WK, et al. (2005) High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart. Br J Nutr 94, 873–876.
28 Nagata, C, Ueno, T, Uchiyama, S, et al. (2008) Dietary and lifestyle correlates of urinary excretion status of equol in Japanese women. Nutr Cancer 60, 49–54.
29 Wu, J, Oka, J, Ezaki, J, et al. (2007) Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause 14, 866–874.
30 Hedlund, TE, Maroni, PD, Ferucci, PG, et al. (2005) Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men. J Nutr 135, 1400–1406.
31 Miyanaga, N, Akaza, H, Takashima, N, et al. (2003) Higher consumption of green tea may enhance equol production. Asian Pac J Cancer Prev 4, 297–301.
32 Hutchins, AM, Slavin, JL & Lampe, JW (1995) Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 95, 545–551.
33 Frankenfeld, CL, Atkinson, C, Thomas, WK, et al. (2004) Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med (Maywood) 229, 902–913.
34 Adlercreutz, H, Honjo, H, Higashi, A, et al. (1991) Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54, 1093–1100.
35 Ozasa, K, Nakao, M, Watanabe, Y, et al. (2005) Association of serum phytoestrogen concentration and dietary habits in a sample set of the JACC study. J Epidemiol 15, Suppl. 2, S196–S202.
36 Duncan, AM, Merz-Demlow, BE, Xu, X, et al. (2000) Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9, 581–586.
37 Lampe, JW, Skor, HE, Li, S, et al. (2001) Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 131, 740–744.
38 Franke, A, Lai, J, Halm, B, et al. (2011) Equol production changes over time in postmenopausal women. J Nutr Biochem .
39 Maskarinec, G, Morimoto, Y, Conroy, S, et al. (2011) The volume of nipple aspirate fluid is not affected by 6 months treatment with soy foods in premenopausal women. J Nutr 141, 626–630.
40 Franke, AA, Hankin, JH, Yu, MC, et al. (1999) Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem 47, 977–986.
41 Messina, M, Nagata, C & Wu, AH (2006) Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1–12.
42 Franke, AA, Halm, BM, Kakazu, K, et al. (2009) Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Test Anal 1, 14–21.
43 Nettleton, JA, Greany, KA, Thomas, W, et al. (2004) Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr 134, 1998–2003.
44 Bonorden, MJ, Greany, KA, Wangen, KE, et al. (2004) Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr 58, 1635–1642.
45 Vedrine, N, Mathey, J, Morand, C, et al. (2006) One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr 60, 1039–1045.
46 Ko, TF, Tsai, HS, Lin, SM, et al. (2010) GC–MS determined distribution of urinary equol producers as affected by age, gender, and repeated ingestions of soymilk. J Food Sci 75, H306–H310.
47 Halm, BM, Franke, AA, Ashburn, LA, et al. (2008) Oral antibiotics decrease urinary isoflavonoid excretion in children after soy consumption. Nutr Cancer 60, 14–22.
48 Lu, LJ, Lin, SN, Grady, JJ, et al. (1996) Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure. Nutr Cancer 26, 289–302.
49 Setchell, KDR, Faughnan, MS, Avades, T, et al. (2003) Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77, 411–419.
50 Kelly, GE, Nelson, C, Waring, MA, et al. (1993) Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 223, 9–22.
51 Coward, L, Barnes, NC, Setchell, KDR, et al. (1993) The antitumor isoflavones, genistein and daidzein, in soybean foods of American and Asian diets. J Agric Food Chem 41, 1961–1967.
52 Xu, X, Wang, H-J, Murphy, PA, et al. (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124, 825–832.
53 Chun, OK, Chung, SJ & Song, WO (2009) Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J Am Diet Assoc 109, 245–254.
54 Wu, J, Oka, J, Higuchi, M, et al. (2006) Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism 55, 423–433.
55 Liu, BH, Qin, LQ, Liu, AP, et al. (2010) Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults. J Epidemiol 20, 377–384.